News

When a stock breaks out above the 20-day simple moving average, good things could be on the horizon. How should investors react?

This article first appeared on GuruFocus. Michael Burry (Trades, Portfolio) still likes Veeva Systems Inc. (VEEV, Financials) as a software play even after he just decreased his position in Big Short investor Michael Burry (Trades, Portfolio)'s portfolio.

The “Big Short” investor says he is redeploying capital from Veeva into “spring-loaded positions” while waiting for PayPal to fall further before adding.

Veeva Systems' recent beat-and-raise quarter has investors feeling bullish.

What the latest earnings and guidance tell you about Veeva Systems Veeva Systems (VEEV) just reported quarterly results that came in ahead of analyst expectations and paired them with higher guidance, putting fresh attention on how its AI focused life sciences cloud products are performing. The company reported second quarter revenue of US$927.96 million compared with US$789.08 million a year earlier. Net income was US$273.43 million compared with US$200.31 million a year ago, with diluted...

Life sciences cloud software provider Veeva Systems (NYSE:VEEV) reported revenue ahead of Wall Street’s expectations in Q2 CY2026, with sales up 17.6% year on year to $928 million. Guidance for next quarter’s revenue was better than expected at $933.5 million at the midpoint, 1.5% above analysts’ estimates. Its non-GAAP profit of $2.35 per share was 5.8% above analysts’ consensus estimates.

VEEV's Q2 fiscal 2027 earnings and revenues top estimates, while strong Vault CRM momentum and a raised full-year outlook drive shares higher.

Veeva Systems stock surges and is having its best day ever after the software company’s quarterly earnings and guidance made Wall Street believers.

The S&P 500 Index ($SPX ) (SPY ) is up by +0.39% today, the Dow Jones Industrial Average ($DOWI ) (DIA ) is up by +0.08%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up by +0.84%. E-mini S&P futures (ESU26 ) are up +0.30%, and September E-mini...

Okta, Salesforce, CrowdStrike, and Veeva topped Nvidia earnings day gains with their own quarterly beats, outperforming the AI darling.

Veeva (VEEV) delivered earnings and revenue surprises of +5.86% and +2.64%, respectively, for the quarter ended July 2026. Do the numbers hold clues to what lies ahead for the stock?

Life sciences cloud software provider Veeva Systems (NYSE:VEEV) reported Q2 CY2026 results beating Wall Street’s revenue expectations, with sales up 17.6% year on year to $928 million. Guidance for next quarter’s revenue was better than expected at $933.5 million at the midpoint, 1.5% above analysts’ estimates. Its non-GAAP profit of $2.35 per share was 5.8% above analysts’ consensus estimates.

Veeva Systems' (VEEV) Vault CRM has cemented its position as the clear market leader in life science

VEEV heads into Q2 with Falcon AI, Vault CRM wins and R&D Cloud growth in focus as revenue and EPS estimates point to double-digit gains.

Software companies' revenue and earnings beat rates accelerated sequentially in the second quarter,

The space company is popular right now, but these other corporations look more attractive.

Gossamer Bio (GOSS) delivered earnings and revenue surprises of -100.00% and +171.71%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Hims & Hers Health (HIMS) delivered earnings and revenue surprises of -42.86% and +9.13%, respectively, for the quarter ended June 2026. Do the numbers hold clues to what lies ahead for the stock?

Based on the average brokerage recommendation (ABR), Veeva (VEEV) should be added to one's portfolio. Wall Street analysts' overly optimistic recommendations cast doubt on the effectiveness of this highly sought-after metric. So, is the stock worth buying?

Veeva Systems (VEEV) is back in focus after the company lifted its fiscal 2027 guidance and signaled higher expected revenue and adjusted EPS, putting upcoming Q2 2027 results firmly on investor radar. See our latest analysis for Veeva Systems. At a share price of US$186.24, Veeva Systems has seen short term momentum pick up, with a 1 month share price return of 15.43% and a 3 month share price return of 15.58%. However, the 1 year total shareholder return is down 35.87%, suggesting the...

A number of stocks jumped in the afternoon session after investors appeared to rotate into oversold enterprise software names amid profit taking in chip stocks.

Don't give up on these stocks yet.

Veeva Systems Inc. (NYSE:VEEV) is one of the 10 Best SaaS Stocks to Buy According to Reddit. According to a June 29 report by Investing.com, Stifel reiterated its $230 price target and maintained a Buy rating on the stock following the company’s acquisition of Copli. Earlier on June 23, Veeva announced the acquisition of the […]

A number of stocks jumped in the afternoon session after Guggenheim's John DiFucci upgraded both Salesforce and ServiceNow to Buy, arguing the AI-disruption fear that gutted the sector during the year had pushed valuations too low. This was a valuation call from a skeptic, not an AI endorsement.

Veeva Systems (NYSE:VEEV) has been selected by UCB to deploy its Safety Suite across the biopharmaceutical company's global operations. The deal focuses on unifying UCB's worldwide pharmacovigilance activities on Veeva's integrated platform. This win expands Veeva's customer base among large global biopharmaceutical companies and highlights uptake of its safety offerings. Veeva Systems, known for its cloud software for life sciences, has been rolling out broader offerings that connect...

Is VEEV a good stock to buy? We came across a bullish thesis on Veeva Systems Inc. on X.com by @tomicki. In this article, we will summarize the bulls’ thesis on VEEV. Veeva Systems Inc.’s share was trading at $188.66 as of June 1st. VEEV’s trailing and forward P/E were 34.68 and 21.28 respectively according to Yahoo […]

Veeva Systems beats Q1 earnings and revenue estimates, raises fiscal 2027 guidance, and expands AI offerings as adoption of its software platforms expands.

Investing.com -- Veeva Systems Inc Class A (NYSE:VEEV) reported first-quarter results that exceeded analyst expectations, with adjusted earnings per share of $2.24 beating the consensus estimate of $2.14 by $0.10. Revenue reached $882.9 million, surpassing the $857.75 million estimate and marking a 16% increase from $759.0 million in the same quarter last year.

US benchmark equity indexes were lower intraday, while oil prices rose amid renewed hostilities in t

Veeva is on the verge of a technical breakout. The beaten-down biopharma software firm's growth outlook is strong, and it's a cash cow with a stellar balance sheet.